GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » COGS-to-Revenue

BGM (BGM Group) COGS-to-Revenue : 0.78 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BGM Group COGS-to-Revenue?

BGM Group's Cost of Goods Sold for the six months ended in Sep. 2024 was $9.83 Mil. Its Revenue for the six months ended in Sep. 2024 was $12.54 Mil.

BGM Group's COGS to Revenue for the six months ended in Sep. 2024 was 0.78.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BGM Group's Gross Margin % for the six months ended in Sep. 2024 was 21.55%.


BGM Group COGS-to-Revenue Historical Data

The historical data trend for BGM Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group COGS-to-Revenue Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
COGS-to-Revenue
Get a 7-Day Free Trial 0.85 0.90 0.90 0.96 0.84

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.92 1.03 0.89 0.78

BGM Group COGS-to-Revenue Calculation

BGM Group's COGS to Revenue for the fiscal year that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=20.983 / 25.098
=0.84

BGM Group's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=9.834 / 12.535
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BGM Group  (NAS:BGM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BGM Group's Gross Margin % for the six months ended in Sep. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 9.834 / 12.535
=21.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


BGM Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BGM Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BGM Group Business Description

Traded in Other Exchanges
N/A
Address
No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

BGM Group Headlines